Michael Wesley Milks

Dr. Michael Wesley Milks

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2022 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
WCWeidan Cao
Weidan Cao
MMMichael Wesley Milks
Michael Wesley Milks
XLXiaofu Liu
Xiaofu Liu
MGMegan E Gregory
Megan E Gregory
DADaniel Addison
Daniel Addison
LLLiang Li
Liang Li
Background: Engagement is essential for the effectiveness of digital behavior change interventions. Existing systematic reviews examining hypertension self-management interventions via mobile apps have primarily focused on intervention efficacy and app usability. Engagement in the prevention or management of hypertension is largely unknown. Objective: This systematic review explores the definition and role of engagement in hypertension-focused mobile health (mHealth) interventions, as well as how determinants of engagement (ie, tailoring and interactivity) have been implemented. Methods: A systematic review of mobile app interventions for hypertension self-management targeting adults, published from 2013 to 2020, was conducted. A total of 21 studies were included in this systematic review. Results: The engagement was defined or operationalized as a microlevel concept, operationalized as interaction with the interventions (ie, frequency of engagement, time or duration of engagement with the program, and intensity of engagement). For all 3 studies that tested the relationship, increased engagement was associated with better biomedical outcomes (eg, blood pressure change). Interactivity was limited in digital behavior change interventions, as only 7 studies provided 2-way communication between users and a health care professional, and 9 studies provided 1-way communication in possible critical conditions; that is, when abnormal blood pressure values were recorded, users or health care professionals were notified. The tailoring of interventions varied at different aspects, from the tailoring of intervention content (including goals, patient education, advice and feedback from health professionals, reminders, and motivational messages) to the tailoring of intervention dose and communication mode. Tailoring was carried out in a number of ways, considering patient characteristics such as goals, preferences, disease characteristics (eg, hypertension stage and medication list), disease self-management experience levels, medication adherence rate, and values and beliefs. Conclusions: Available studies support the importance of engagement in intervention effectiveness as well as the essential roles of patient factors in tailoring, interactivity, and engagement. A patient-centered engagement framework for hypertension self-management using mHealth technology is proposed here, with the intent of facilitating intervention design and disease self-management using mHealth technology.

1 February 2020 in JACC
Verified
Journal Article
Closed access
JBJanice M. Bonsu
Janice M. Bonsu
Avirup GuhaAvirup Guha
Avirup Guha
LCLawrence Charles
Lawrence Charles
VYVedat O. Yildiz
Vedat O. Yildiz
LWLai Wei
Lai Wei
DADaniel Addison
Daniel Addison

1 March 2009 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
RRRichard T. Robinson
Richard T. Robinson
JWJing Wang
Jing Wang
JCJames G. Cripps
James G. Cripps
MMMichael Wesley Milks
Michael Wesley Milks
KEKathryn A English
Kathryn A English
JGJames D. Gorham
James D. Gorham
Fulminant inflammation in the liver is often accompanied by the accumulation of IFN-γ-producing T cells. The BALB/c-Tgfb1−/− mouse exhibits extensive, spontaneously developing necroinflammation in the liver, accompanied by the accumulation of IFN-γ-producing CD4+ and CD8+ T cells. Liver damage depends on the presence of an intact Ifng gene. We determined the relevant cellular source(s) of IFN-γ. In Tgfb1−/− liver, CD4+ T cells were more numerous than CD8+ T cells and NK cells, and produced more IFN-γ. Depletion of CD4+ T cells eliminated both the elevation in plasma IFN-γ and aspartate aminotransferase, whereas depletion of CD8+ T cells did not. Rag1−/−Tgfb1−/− mice exhibited neither IFN-γ elevation nor tissue damage, indicating that NK cells are not sufficient. IFN-γ was required for strong overexpression of class II genes but not for CD4+ T cell activation, oligoclonal expansion, or accumulation in the liver. The T cell inhibitory molecule PD-L1 was strongly expressed in Tgfb1−/− livers, ruling out a lack of PD-L1 expression as an explanation for aberrant liver T cell activation. Finally, whereas Tgfb1−/− CD4+ T cells overexpressed Fas ligand, hepatocellular damage was observed in Faslpr/lprTgfb1−/− mice, indicating that liver pathology is Fas independent. We conclude that liver damage in this model of fulminant autoimmune hepatitis is driven by CD4+ T cell production of IFN-γ, is independent of both CD8+ T cells and the Fas ligand/Fas pathway, and is not explained by a lack of PD-L1 expression.

1 July 2012 in The American Journal of Pathology
Verified
Journal Article
Open access
ZHZachary M. Huttinger
Zachary M. Huttinger
MMMichael Wesley Milks
Michael Wesley Milks
MNMichael S. Nickoli
Michael S. Nickoli
WAWilliam L. Aurand
William L. Aurand
LLLawrence C. Long
Lawrence C. Long
RGRichard J. Gumina
Richard J. Gumina
Modulation of purinergic signaling, which is critical for vascular homeostasis and the response to vascular injury, is regulated by hydrolysis of proinflammatory ATP and/or ADP by ectonucleoside triphosphate diphosphohydrolase 1 (ENTPD-1; CD39) to AMP, which then is hydrolyzed by ecto-5'-nucleotidase (CD73) to adenosine. We report here that compared with littermate controls (wild type), transgenic mice expressing human ENTPDase-1 were resistant to the formation of an occlusive thrombus after FeCl(3)-induced carotid artery injury. Treatment of mice with the nonhydrolyzable ADP analog, adenosine-5'-0-(2-thiodiphosphate) trilithium salt, Ado-5'-PP[S], negated the protection from thrombosis, consistent with a role for ADP in platelet recruitment and thrombus formation. ENTPD-1 expression decreased whole-blood aggregation after stimulation by ADP, an effect negated by adenosine-5'-0-(2-thiodiphosphate) trilithium salt, Ado-5'-PP[S] stimulation, and limited the ability to maintain the platelet fibrinogen receptor, glycoprotein α(IIb)/β(3), in a fully activated state, which is critical for thrombus formation. In vivo treatment with a CD73 antagonist, a nonselective adenosine-receptor antagonist, or a selective A(2A) or A(2B) adenosine-receptor antagonist, negated the resistance to thrombosis in transgenic mice expressing human ENTPD-1, suggesting a role for adenosine generation and engagement of adenosine receptors in conferring in vivo resistance to occlusive thrombosis in this model. In summary, our findings identify ENTPDase-1 modulation of purinergic signaling as a key determinant of the formation of an occlusive thrombus after vascular injury.

1 April 2018 in The American Journal of Cardiology
Verified
Journal Article
Closed access
MMMichael Wesley Milks
Michael Wesley Milks
MVMichael R. Velez
Michael R. Velez
NMNishaki Mehta
Nishaki Mehta
AIAbiodun Ishola
Abiodun Ishola
THThomas Van Houten
Thomas Van Houten
DODavid A. Orsinelli
David A. Orsinelli

3 September 2009 in Liver International
Verified
Journal Article
Closed access
PDF file
MMMichael Wesley Milks
Michael Wesley Milks
JCJames G. Cripps
James G. Cripps
HLHeping Lin
Heping Lin
JWJing Wang
Jing Wang
RRRichard T. Robinson
Richard T. Robinson
JGJames D. Gorham
James D. Gorham